Subsidised Genetic Testing for Breast and Ovarian Cancer Starts in Singapore on December 1
Published
Subsidised genetic testing for hereditary breast and ovarian cancer, known as HBOC, will begin on December 1 at three cancer clinics in Singapore. The test helps doctors find out whether a person has inherited genetic changes that increase the risk of these cancers.
Before the subsidy, the test costs about $1,000. The government support will make the test more affordable for patients who are eligible. The three clinics that will offer the testing were not named in the short report, so patients who are interested should check with their doctors for more details.
Hereditary breast and ovarian cancer runs in some families. People who have a genetic change linked to these cancers may be advised to take extra steps, such as more regular screening or preventive measures, to protect their health. Doctors also use test results to advise family members who may share the same genetic risk.
The launch of subsidised testing is a step towards making genetic screening more available to people in Singapore. Those who want more information about eligibility and how to book an appointment are advised to contact their healthcare providers.
Sources: The Straits Times
More Singapore news
- Singapore Needs More Tech Companies to Grow Its Stock Market, HSBC Strategist Says
- Singapore Tech Shares Rebound After Last Week's Sell-Off
- Databricks Plans to Double Its Singapore Team to 500 Staff
- Visa Sets Up Six Technology Hubs in New Singapore Centre
- US Congress Faces Possible Impeachment Fight Over Defence Secretary Pete Hegseth
- Giving Former Politicians Room to Return to Normal Life in Singapore
- Singapore Cloud Firm Megaspeed Faces Renewed US Scrutiny
- Iran Calls for Stronger Economic and Trade Ties with Singapore